Toggle Main Menu Toggle Search

Open Access padlockePrints

Comparing Mortality in Patients with Atrial Fibrillation who are Receiving a Direct Oral Anticoagulant or Warfarin: A Meta-analysis of Randomized Trials

Lookup NU author(s): Dr Aaron Liew

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

BackgroundIn patients with nonvalvular atrial fibrillation (AF), direct oral anticoagulants (DOACs) are at least non-inferior to warfarin for the prevention of stroke and systemic embolism. The main objective of this study was to obtain reliable and precise estimates for all-cause mortality, vascular mortality and bleeding mortality in patients with AF receiving a DOAC or warfarin for stroke prevention.MethodsMeta-analysis was performed on phase 3 randomized trials which compared a DOAC with warfarin for stroke prevention in AF. Published data was pooled using the DerSimonian random-effect model using Revman 5.2 and Comprehensive Meta Analysis software version 2. The results were presented as risk ratios (RR), absolute risk reduction (ARR) and number-needed-to-treat (NNT).ResultsA total of 71,683 patients were included in this meta-analysis from 4 randomized controlled trials (median patient follow-up: 1.8 to 2.8 years) which compared a DOAC with warfarin for stroke prevention in AF. When compared with warfarin, DOACs significantly reduced all-cause mortality (RR: 0.89; 95% CI: 0.85-0.94; ARR: 0.76%; 95% CI: 0.39-1.13%; NNT = 132), vascular mortality (RR: 0.88; 95% CI: 0.82-0.94; ARR: 0.53%; 95% CI: 0.23-0.83%; NNT=189), and bleeding mortality (RR: 0.54; 95% CI: 0.44-0.67; ARR: 0.32%; 95% CI: 0.21-0.43%; NNT=313).ConclusionCompared with warfarin therapy for stroke prevention in patients with AF, DOACs significantly reduce all-cause mortality, vascular mortality and bleeding mortality. This mortality benefit appears to be driven by the reduction in vascular- and bleeding-related mortality which, in turn, may be related to the reduction in intracranial bleeding.


Publication metadata

Author(s): Liew A, O'Donnell M, Douketis J

Publication type: Article

Publication status: Published

Journal: Journal of Thrombosis and Haemostasis

Year: 2014

Volume: 12

Issue: 9

Pages: 1419-1424

Print publication date: 01/09/2014

Online publication date: 25/07/2014

Acceptance date: 15/06/2014

ISSN (print): 1538-7933

ISSN (electronic): 1538-7836

Publisher: Wiley-Blackwell Publishing

URL: http://dx.doi.org/10.1111/jth.12651

DOI: 10.1111/jth.12651

PubMed id: 24986568


Altmetrics

Altmetrics provided by Altmetric


Share